NCT06439407View on ClinicalTrials.gov

Clinical Trial to Preliminarily Assess the Safety and Feasibility of SAT-014, a Software for Alleviating Symptoms of Trauma and Stress-related Disorders

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 3, 2024

Primary Completion Date

June 28, 2024

Study Completion Date

August 30, 2024

Conditions
Posttraumatic Stress Disorder
Interventions
DEVICE

SAT-014(Software as Medical Device)

SAT-014(Software as Medical Device) + maintain previous treatment

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

S-Alpha Therapeutics, Inc.

INDUSTRY

NCT06439407 - Clinical Trial to Preliminarily Assess the Safety and Feasibility of SAT-014, a Software for Alleviating Symptoms of Trauma and Stress-related Disorders | Biotech Hunter | Biotech Hunter